Site notifications

Sub menu

 
 

Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013

The documents released under Section 11C of the Freedom of Information Act 1982 have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Contact Officer by emailing foi@health.gov.au or calling the Department of Health and Ageing on 1800 020 103 or 02 6289 1555.

Date of release FOI number Documents
1 Jul 2013 to 30 Jun 2014 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014
13 June 2013 206-1213

Bioequivalence data
13 June 2013 180-1213

Documents relating to the safety of esomeprazole and strontium
7 May 2013 181-1213

Correspondence with the Australian Vaccination Network regarding complaints for Black Salve advertisements
18 April 2013 156-1213

Fluoridated water and fluoride chemicals as Excluded Therapeutic Goods
15 April 2013 173-1213

Zometa PI/CMI information
11 April 2013 178-1213

All products approved via Special Access Scheme 2012
11 April 2013 176-1213

Correspondence with PIP silicone suppliers
11 April 2013 152-1213

Correspondence with PIP silicone suppliers
25 March 2013 172-1213

Reports or Ministerial briefs as a result of Project Aperio.
15 March 2013 122-1011

Qualifications of a clinical assessor.
7 February 2013 090-1213

Margron prosthetic hip.
24 December 2012 106-1213

Requests from Defence pertaining to the importation of therapeutic goods between 1990-1991.
20 November 2012 079-1213

Documents regarding cancelled ARTG entries for sunscreens.
12 November 2012 048-1213

A copy of the TGA's assessment of gifts for the last 5 years.
25 October 2012 075-1213

Requests from the Department of Defence - Pyridostigmine Bromide 30mg.
14 September 2012 021-1213

Current Australian manufacturers licensed to transport, store, manufacture or release cord blood, haematopoietic progenitor cells or cord tissue for autologous use or directed allogenic use.
13 August 2012 332-1112

Documents about granting by the TGA to Specsavers Pty Ltd of approval under s.42DF to use a restricted representation.
10 August 2012 316-1112

Information relating to a staffing matter.
26 July 2012 305-1112

TGA evaluation report for paracetamol actavis.
20 July 2012 356-1112

Date of entry onto ARTG of Braeznor Device - Custom Cervical Buttress and any complaints in relation to Braeznor Device - Custom Cervical Buttress.
20 July 2012 351-1112

Documents from manufacturer of Poly Implant Prostheses silicone breast implants, providing information to surgeons and patients about their use.
13 July 2012 216-1112

Advice given to TGA by National Industrial Chemicals Notification Assessment Scheme, and the Office of Chemical Safety regarding the potential health risk posed by phthalates in medical devices.
12 July 2012 347-1112

Copies of all Office of Complementary Medicines procedures and policies relating to compositional guidelines.
5 July 2012 333-1112

Complaints handling procedures and policies for complaints made against the TGA.
2 July 2012 314-1112

Documents relating to FOI applicant's new substance applications to the Office of Complementary Medicines in the Therapeutic Goods Administration.
1 Jul 2011 to 30 Jun 2012 Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Topics

Help us improve the Therapeutic Goods Administration site